SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827809-18-000016
Filing Date
2018-05-10
Accepted
2018-05-10 08:58:11
Documents
67
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvln-033118x10qclassic.htm   iXBRL 10-Q 841221
2 EXHIBIT 31.1 a20180331exhibit311cla.htm EX-31.1 12378
3 EXHIBIT 31.2 a20180331exhibit312cla.htm EX-31.2 12365
4 EXHIBIT 32.1 a20180331exhibit321cla.htm EX-32.1 6027
5 EXHIBIT 32.2 a20180331exhibit322cla.htm EX-32.2 6143
  Complete submission text file 0000827809-18-000016.txt   4316816

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvln-20180331.xsd EX-101.SCH 35520
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvln-20180331_cal.xml EX-101.CAL 68791
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvln-20180331_def.xml EX-101.DEF 145586
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvln-20180331_lab.xml EX-101.LAB 385839
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvln-20180331_pre.xml EX-101.PRE 252823
11 EXTRACTED XBRL INSTANCE DOCUMENT nvln-033118x10qclassic_htm.xml XML 672576
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17082 | Film No.: 18820708
SIC: 2834 Pharmaceutical Preparations